A Phase 1, Open-label, Crossover Study To Evaluate The Bioequivalence Of Intramuscular And Subcutaneous Peginterferon Beta-1a In Healthy Volunteers

被引：0
|
作者：
Zhao, Y. [1 ]
Chen, K. [1 ]
Ramia, N. [1 ]
Sahu, S. [1 ]
Kumar, A. [1 ]
Naylor, M. L. [1 ]
Zhu, L. [1 ]
Butts, C. [1 ]
机构：
[1] Biogen, Cambridge, MA USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 1_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P047
引用
收藏
页码：37 / 38
页数：2
相关论文
共 50 条
  • [21] Pharmacokinetics and Bioequivalence of 2 Azithromycin Tablet Formulations: A Randomized, Open-Label, 2-Stage Crossover Study in Healthy Volunteers
    Leong, Chuei Wuei
    Yee, Kar Ming
    Nalaiya, Jeyashanthini
    Kassim, Zawahil
    Rahim, Sharifah Radziah Syed Abd
    Ahmad, Shahnun
    Amran, Atiqah
    Krishnamurthy, Lakshman
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (09): : 1078 - 1083
  • [22] Combination therapy with intramuscular interferon beta-1a and oral doxycycline in patients with multiple sclerosis: An open-label trial
    Minagar, A
    Alexander, JS
    Brooks, R
    Kelley, RE
    Schwendimann, RN
    Gonzalez-Toledo, E
    Bryan, DM
    [J]. NEUROLOGY, 2006, 66 (05) : A34 - A34
  • [23] An open-label trial of combination therapy with intramuscular interferon beta-1a and oral doxycycline in patients with multiple sclerosis
    Minagar, A
    Alexander, JS
    Brooks, R
    Kelley, RE
    Gonzalez-Toledo, E
    [J]. MULTIPLE SCLEROSIS, 2005, 11 : S79 - S79
  • [24] Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study
    Wang, Yanli
    Deng, Qiaohuan
    Gao, Zhenyue
    Liu, Guangwen
    Su, Zhengjie
    Zhao, Yicheng
    Zhang, Lixiu
    Yang, Haimiao
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [25] Tolerability and safety of facilitated subcutaneous immunoglobulin 20% in healthy adults: a phase 1 open-label study
    Nagy, Andras
    Khaskhely, Noor
    Duff, Kimberly
    Bauer, Alexander
    Okonneh, Fred
    Rondon, Juan Carlos
    Yel, Leman
    Li, Zhaoyang
    [J]. CLINICAL IMMUNOLOGY, 2023, 250 : 36 - 36
  • [26] A Matching-adjusted Indirect Comparison of Clinical Effectiveness of Subcutaneous Peginterferon Beta-1a and Intramuscular Interferon Beta-1a for the Treatment of Relapsing Multiple Sclerosis
    Scott, Thomas
    Shang, Shulian
    Castrillo-Viguera, Carmen
    [J]. NEUROLOGY, 2017, 88
  • [27] Bioequivalence evaluation of perampanel oral suspension and tablet formulations in healthy subjects: a Phase I, open-label, crossover study
    Laurenza, Antonio
    Hall, Nancy
    Majid, Oneeb
    Rege, Bhaskar
    [J]. NEUROLOGY, 2017, 88
  • [28] Isotretinoin conundrum: a randomized, open-label, crossover study in Mexico to evaluate the bioavailability and bioequivalence of three pharmaceutical preparations of isotretinoin in healthy participants
    Pineyro-Garza, Everardo
    Gomez-Silva, Magdalena
    Gamino Pena, Maria Elena
    Palmer, Jonathan
    Berber, Arturo
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2015, 53 (10) : 897 - 904
  • [29] A Randomized, Open-Label, Crossover Phase 1 Study to Evaluate the Effects of Food on the Pharmacokinetics of a Single Oral Dose of a 15-mg Tylerdipine Tablet in Healthy Chinese Male Volunteers
    Wang, Lu
    Xie, Lijun
    Zhou, Sufeng
    Wang, Yuanyuan
    Chen, Juan
    Zhou, Yanli
    Liu, Yun
    Zhang, Hongwen
    Tao, Mingxue
    Ou, Ning
    Shao, Feng
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2019, 8 (01): : 126 - 132
  • [30] Bioequivalence Study of Two Tablet Formulations of Clonazepam 2 mg: A Randomized, Open-Label, Crossover Study in Healthy Mexican Volunteers Under Fasting Conditions
    Genis-Najera, Luis
    Sanudo-Maury, Maria Elena
    [J]. NEUROLOGY AND THERAPY, 2024, 13 (01) : 141 - 152
12345